Fosaprepitant Weekly vs Every 3 Weeks for the Prevention of Concurrent Chemoradiotherapy–Induced Nausea and Vomiting: A Pilot Randomized Clinical Trial.
- Resource Type
- Article
- Source
- JAMA Network Open; 7/27/2023, Vol. 6 Issue 7, pe2326127-e2326127, 1p
- Subject
- Language
- ISSN
- 25743805